Literature DB >> 23090632

Staging and neuroprogression in bipolar disorder.

Gabriel Rodrigo Fries1, Bianca Pfaffenseller, Laura Stertz, André Vinicius Contri Paz, Aroldo Ayub Dargél, Maurício Kunz, Flávio Kapczinski.   

Abstract

The apparently progressive nature of a considerable proportion of cases of bipolar disorder (BD) has been acknowledged in recently proposed clinical staging models. This has been part of an attempt to facilitate and refine diagnosis, treatment selection, and establish a prognosis. The study of the progressive nature of some cases of BD has given raise to the hypothesis of neuroprogression, which postulates that different stages of BD are associated with distinct neurobiological underpinnings. Given that BD may be intimately associated with chronic stress response and coping mechanisms over the course of illness, we propose that cellular resilience mechanisms may play a key role in the neuroprogression in BD. In the present study, we review neuroanatomical evidence of the progression that occurs in many cases of BD, as well as cellular resilience mechanisms and peripheral biomarkers associated with distinct stages of this disorder. In summary, cellular resilience mechanisms seem to be less efficient at later stages of BD, especially mitochondrial and endoplasmic reticulum-related responses to stress. These insights may help in developing staging models of BD, with a special emphasis on the search for biomarkers associated with illness progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23090632     DOI: 10.1007/s11920-012-0319-2

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  95 in total

Review 1.  The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings.

Authors:  S M Strakowski; M P Delbello; C M Adler
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

Review 2.  Staging bipolar disorder.

Authors:  Eduard Vieta; M Reinares; A R Rosa
Journal:  Neurotox Res       Date:  2010-05-12       Impact factor: 3.911

Review 3.  Evidence and implications for early intervention in bipolar disorder.

Authors:  Michael Berk; Karen Hallam; Gin S Malhi; Lisa Henry; Melissa Hasty; Craig Macneil; Murat Yucel; Chris Pantelis; Brendan Murphy; Eduard Vieta; Seetal Dodd; Patrick D McGorry
Journal:  J Ment Health       Date:  2010-04

4.  Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.

Authors:  S L Eastwood; P J Harrison
Journal:  Brain Res Bull       Date:  2001-07-15       Impact factor: 4.077

5.  Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.

Authors:  Terence A Ketter; John P Houston; David H Adams; Richard C Risser; Adam L Meyers; Douglas J Williamson; Mauricio Tohen
Journal:  J Clin Psychiatry       Date:  2006-01       Impact factor: 4.384

6.  Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers.

Authors:  Izabela Guimarães Barbosa; Natalia Pessoa Rocha; Rodrigo Barreto Huguet; Rodrigo A Ferreira; João Vinícius Salgado; Livia A Carvalho; Carmine M Pariante; Antônio Lúcio Teixeira
Journal:  J Affect Disord       Date:  2012-01-16       Impact factor: 4.839

7.  Limbic and corpus callosum aberrations in adolescents with bipolar disorder: a tract-based spatial statistics analysis.

Authors:  Naama Barnea-Goraly; Kiki D Chang; Asya Karchemskiy; Meghan E Howe; Allan L Reiss
Journal:  Biol Psychiatry       Date:  2009-04-22       Impact factor: 13.382

8.  Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder.

Authors:  Joseph F Goldberg; Carrie L Ernst
Journal:  J Clin Psychiatry       Date:  2002-11       Impact factor: 4.384

9.  Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder.

Authors:  Tatiana Perova; Michael J Wasserman; Peter P Li; Jerry J Warsh
Journal:  Int J Neuropsychopharmacol       Date:  2007-08-06       Impact factor: 5.176

10.  The role of BDNF as a mediator of neuroplasticity in bipolar disorder.

Authors:  Iria Grande; Gabriel Rodrigo Fries; Mauricio Kunz; Flavio Kapczinski
Journal:  Psychiatry Investig       Date:  2010-12-15       Impact factor: 2.505

View more
  31 in total

1.  Changes in the corpus callosum in women with late-stage bipolar disorder.

Authors:  L Lavagnino; B Cao; B Mwangi; M-J Wu; M Sanches; G B Zunta-Soares; F Kapczinski; J Soares
Journal:  Acta Psychiatr Scand       Date:  2015-01-31       Impact factor: 6.392

2.  Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder.

Authors:  Margo W Menkes; Kristan Armstrong; Jennifer Urbano Blackford; Stephan Heckers; Neil D Woodward
Journal:  Schizophr Res       Date:  2018-10-26       Impact factor: 4.939

Review 3.  Inflammatory mediators of cognitive impairment in bipolar disorder.

Authors:  Isabelle E Bauer; Michaela C Pascoe; Bianca Wollenhaupt-Aguiar; Flavio Kapczinski; Jair C Soares
Journal:  J Psychiatr Res       Date:  2014-05-02       Impact factor: 4.791

4.  Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele.

Authors:  Bo Cao; Isabelle E Bauer; Ajaykumar N Sharma; Benson Mwangi; Thomas Frazier; Luca Lavagnino; Giovana B Zunta-Soares; Consuelo Walss-Bass; David C Glahn; Flavio Kapczinski; David A Nielsen; Jair C Soares
Journal:  J Affect Disord       Date:  2016-03-10       Impact factor: 4.839

5.  Brain structure-function associations in multi-generational families genetically enriched for bipolar disorder.

Authors:  Scott C Fears; Remmelt Schür; Rachel Sjouwerman; Susan K Service; Carmen Araya; Xinia Araya; Julio Bejarano; Emma Knowles; Juliana Gomez-Makhinson; Maria C Lopez; Ileana Aldana; Terri M Teshiba; Zvart Abaryan; Noor B Al-Sharif; Linda Navarro; Todd A Tishler; Lori Altshuler; George Bartzokis; Javier I Escobar; David C Glahn; Paul M Thompson; Carlos Lopez-Jaramillo; Gabriel Macaya; Julio Molina; Victor I Reus; Chiara Sabatti; Rita M Cantor; Nelson B Freimer; Carrie E Bearden
Journal:  Brain       Date:  2015-05-05       Impact factor: 13.501

Review 6.  Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder.

Authors:  Cynthia V Calkin
Journal:  Ann Med       Date:  2019-08-27       Impact factor: 4.709

Review 7.  Neuroprogression and Cognitive Functioning in Bipolar Disorder: A Systematic Review.

Authors:  Taiane Cardoso; Isabelle E Bauer; Thomas D Meyer; Flavio Kapczinski; Jair C Soares
Journal:  Curr Psychiatry Rep       Date:  2015-09       Impact factor: 5.285

Review 8.  Modeling mania in preclinical settings: A comprehensive review.

Authors:  Ajaykumar N Sharma; Gabriel R Fries; Juan F Galvez; Samira S Valvassori; Jair C Soares; André F Carvalho; Joao Quevedo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-11-04       Impact factor: 5.067

Review 9.  Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention.

Authors:  Adam J Walker; Yesul Kim; J Blair Price; Rajas P Kale; Jane A McGillivray; Michael Berk; Susannah J Tye
Journal:  Front Psychiatry       Date:  2014-04-09       Impact factor: 4.157

Review 10.  Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview.

Authors:  Enrique L M Ochoa
Journal:  Cell Mol Neurobiol       Date:  2021-08-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.